Madison Square Garden: Q4 Earnings Insights

Madison Square Garden (NYSE:MSGE) reported its Q4 earnings results on Friday, August 19, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Madison Square Garden (NYSE:MSGE) reported its Q4 earnings results on Friday, August 19, 2022 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Madison Square Garden missed estimated earnings by 250.0%, reporting an EPS of $-1.89 versus an estimate of $-0.54.

Revenue was up $353.76 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.41 which was followed by a 1.27% drop in the share price the next day.

Here’s a look at Madison Square Garden’s past performance:

Quarter Q3 2022 Q2 2022 Q1 2022 Q4 2021
EPS Estimate 0.04 1 -1.14 -3.31
EPS Actual -0.37 0.07 -2.55 -4.87
Revenue Estimate 441.64M 538.98M 281.24M 60.20M
Revenue Actual 460.13M 516.44M 294.51M 99.78M

To track all earnings releases for Madison Square Garden visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Canopy Growth Reports 7% YoY Drop In Q3 Revenue, CEO Touts ‘New Era’ For Company As It Seeks US Listing

Canopy Growth reported an 81% YoY increase in "rest-of-world" cannabis revenue for Q3 2024. The company attributed the growth to strong performance in Australia and a return to growth in Europe. Canopy also announced its plans for the US cannabis market through its non-controlling interest in Canopy USA. The company expects to file its definitive proxy statement with the SEC on or about 13 February, followed by a special meeting with shareholders on 12 April. During the meeting, shareholders will consider the creation of a new class of non-voting, non-participating exchangeable shares. Once exchangeable shares are created and Canopy USA acquires US THC businesses, investors are expected to have an opportunity to participate in the US cannabis market.

CGC